đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0159)
Start Date
2019-06-19
Trial ID
NCT03893448
Treatments Being Tested
The goal of this study is to evaluate the safety, tolerability, and immunog...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0015)
Start Date
2018-10-18
Trial ID
NCT03620162
Treatments Being Tested
As measles-mumps-rubella (MMR) vaccination is established as routine childh...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-03
Trial ID
NCT00353288
Treatments Being Tested
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Kaiser Permanente - Los Angeles Medical Center- Site Number : 8400025
Start Date
2025-02-27
Trial ID
NCT06824181
The purpose of the primary phase of the study is to demonstrate the non-inf...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06-01
Trial ID
NCT00326118
An observer-blind study to evaluate GlaxoSmithKline Biologicals' live atten...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-09-01
Trial ID
NCT00226499
Treatments Being Tested
This study will compare ProQuad⢠and concomitant administration of M-M-R⢠I...
Status
Terminated
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00839917
The present study will explore the immunogenicity of AVAXIM⢠80U-Pediatric ...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00313950
The purpose of this study is to assess non-inferiority of two different vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-09
Trial ID
NCT00969436
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity and imm...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03
Trial ID
NCT00263653
Treatments Being Tested